A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects

Completed · Phase 1

Conditions studied: Type 2 Diabetes Mellitus

In brief

The study is designed to investigate the effect of repeated dosing of PF-05175157 on the pharmacokinetics of a single dose of Simvastatin in healthy adult subjects.

Key facts

Study ID

NCT01469468

Run by

Pfizer

People needed

14

Starts

2011-11-01

Expected to finish

2011-12-01

Last updated by the study team

2018-11-14

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy subjects with normal results in all screening examinations.
• Body Mass Index of 17.5 to 35.5 kg/m2

You may not qualify if…

• Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, ocular, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies, but excluding untreated, asymptomatic, seasonal allergies at time of dosing).
• Known history of intolerance to simvastatin or other statins.

Where it is running

• Pfizer Investigational Site — South Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.